184 related articles for article (PubMed ID: 21113230)
1. [Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].
Azancot MA; Agraz Pamplona I; Fort Ros J; Marín Valencia A; Gil Carballeira I; Camps Domenech J
Nefrologia; 2010; 30(6):710-2. PubMed ID: 21113230
[No Abstract] [Full Text] [Related]
2. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
[No Abstract] [Full Text] [Related]
3. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.
Zand L; Specks U; Sethi S; Fervenza FC
Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
Wendt M; Gunnarsson I; Bratt J; Bruchfeld A
Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
[No Abstract] [Full Text] [Related]
6. Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab.
Lo Gullo A; Bajocchi G; Cassone G; Cavazza A; Zanichelli M; Salvarani C
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S138. PubMed ID: 24021545
[No Abstract] [Full Text] [Related]
7. [ANCA associated vasculitis and PRGN].
Arimura Y; Kawashima S; Yoshihara K
Nihon Jinzo Gakkai Shi; 2009; 51(2):88-93. PubMed ID: 19378792
[No Abstract] [Full Text] [Related]
8. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Hoffman GS
Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
[No Abstract] [Full Text] [Related]
9. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
10. [Microscopic polyangiitis].
Pagnoux C; Guilpain P; Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):895-901. PubMed ID: 17350793
[TBL] [Abstract][Full Text] [Related]
11. Update on the management of systemic vasculitis: what did we learn in 2009?
Hellmich B
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):98-103. PubMed ID: 20412713
[TBL] [Abstract][Full Text] [Related]
12. Ofatumumab for rituximab-resistant nephrotic syndrome.
Basu B
N Engl J Med; 2014 Mar; 370(13):1268-70. PubMed ID: 24670185
[No Abstract] [Full Text] [Related]
13. [C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab].
Aldasoro-Cáceres V; Aldasoro-Cáceres I; Pérez-Moreiras JV; Murié-Fernández M; Ibáñez-Bosch R
Arch Soc Esp Oftalmol; 2014 Jan; 89(1):31-4. PubMed ID: 24269385
[TBL] [Abstract][Full Text] [Related]
14. [Churg-Strauss syndrome].
Lhote F
Presse Med; 2007 May; 36(5 Pt 2):875-89. PubMed ID: 17408916
[TBL] [Abstract][Full Text] [Related]
15. [How to treat systemic necrotizing vasculitides?].
Guillevin L
Presse Med; 2012 Oct; 41(10):1024-30. PubMed ID: 22906773
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for ANCA-associated vasculitides.
Guillevin L
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S118-21. PubMed ID: 24854382
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
Murakami C; Manoharan P; Carter-Monroe N; Geetha D
Transpl Int; 2013 Dec; 26(12):1225-31. PubMed ID: 24118474
[TBL] [Abstract][Full Text] [Related]
18. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Schönermarck U; Rau S; Fischereder M
N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083401
[No Abstract] [Full Text] [Related]
19. Treat-to-target in vasculitis: is this a sensible approach?
Luqmani RA
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S149-53. PubMed ID: 23079158
[TBL] [Abstract][Full Text] [Related]
20. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Hebert LA; Ardoin S; Shim RL
N Engl J Med; 2010 Nov; 363(21):2072-3; author reply 2073-4. PubMed ID: 21083399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
